BioAdvance Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
157
- Portfolio
-
47
- Exits
-
45
BioAdvance General Information
Company Description
Founded in 2002, BioAdvance is a venture capital investment firm based in Conshohocken, Pennsylvania. The firm prefers to invest in early-stage companies operating in the healthcare and life sciences, focusing on therapeutics, medical devices, research tools, diagnostics, and health information technology in the mid-Atlantic region.
Business Details
Website
www.bioadvance.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 101 West Elm Street
- Suite 330
- Conshohocken, PA 19428
- United States
BioAdvance Investments (157)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Palvella Therapeutics | 24-Jul-2024 | PIPE | Drug Discovery | Profitable | ||
Aspicio Therapeutics | 18-Jun-2024 | Other Pharmaceuticals and Biotechnology | Stealth | |||
Senzo Health | 07-Jun-2024 | Other Devices and Supplies | Generating Revenue | |||
ChyloMetis | 29-May-2024 | Drug Discovery | Stealth | |||
Keriton | 02-May-2024 | Enterprise Systems (Healthcare) | Generating Revenue | |||
Latus Bio | 30-Apr-2024 | Drug Discovery | Pre-Clinical Trials | |||
ImmunoGenesis | 02-Apr-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
ViTToria Biotherapeutics | 01-Jan-2024 | Drug Discovery | Pre-Clinical Trials | |||
Ride Health | 26-Dec-2023 | Later Stage VC | Other Healthcare Technology Systems | Generating Revenue | ||
SIRPant Immunotherapeutics | 22-Dec-2023 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
BioAdvance Exits (45)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Hsiri Therapeutics | 01-Jan-2024 | Secondary Transaction - Private | |
Envara Health | 30-Jan-2023 | ||
CrossBridge Health | 19-Oct-2022 | ||
Innovative Supply Solutions | 12-Sep-2022 | ||
PeriRx | 24-Jun-2022 | ||
Microbiota Therapeutics | 01-Jan-2022 | ||
Renovacor | 02-Sep-2021 | ||
Allevi (Other Devices and Supplies) | 06-May-2021 | ||
Anakim Biologics | 01-Feb-2021 | Secondary Transaction - Private | |
Pillo Health | 30-Oct-2020 | Merger/Acquisition |
BioAdvance Investments by Industry, Year, and Region
BioAdvance Management, Team & Partners (16)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
David Shin MD | Venture Partner | Conshohocken, PA | |||
Frederick Jones MD | Partner | Conshohocken, PA | |||
Gregory Harriman MD | Partner | Conshohocken, PA | |||
Robert Driscoll | Director of Finance | Conshohocken, PA | |||
Marnie McCoy | Program Director | Conshohocken, PA |
BioAdvance Co-Investors (123)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Ben Franklin Technology Partners of Southeastern Pennsylvania | 12 | ||||
BroadOak Capital Partners | |||||
Dreamit Ventures | |||||
Remiges Ventures | |||||
University of Pennsylvania Health System |
BioAdvance FAQs
-
What is BioAdvance?
Founded in 2002, BioAdvance is a venture capital investment firm based in Conshohocken, Pennsylvania.
-
When was BioAdvance founded?
BioAdvance was founded in 2002.
-
Who is the CEO of BioAdvance?
Shahram Hejazi Ph.D is the CEO of BioAdvance.
-
Where is BioAdvance headquartered?
BioAdvance is headquartered in Conshohocken, PA.
-
What is BioAdvance's total asset value?
BioAdvance has around
in total assets under management. -
How many investments has BioAdvance made?
BioAdvance has made 157 investments.
-
What has BioAdvance invested in?
BioAdvance has made numerous investments in companies like Palvella Therapeutics, Aspicio Therapeutics, and Senzo Health within the Drug Discovery, Pharmaceuticals and Biotechnology, and Devices and Supplies industries.
-
What has BioAdvance invested in recently?
BioAdvance's latest investment was on 24-Jul-2024 in Palvella Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »